352 related articles for article (PubMed ID: 30312400)
1. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A;
Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400
[TBL] [Abstract][Full Text] [Related]
2. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
Solanky D; Pardi DS; Loftus EV; Khanna S
Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
[TBL] [Abstract][Full Text] [Related]
3. Management of inflammatory bowel disease with
D'Aoust J; Battat R; Bessissow T
World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
[TBL] [Abstract][Full Text] [Related]
5. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
[TBL] [Abstract][Full Text] [Related]
8. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.
Ananthakrishnan AN; Guzman-Perez R; Gainer V; Cai T; Churchill S; Kohane I; Plenge RM; Murphy S
Aliment Pharmacol Ther; 2012 Apr; 35(7):789-95. PubMed ID: 22360370
[TBL] [Abstract][Full Text] [Related]
9. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
[TBL] [Abstract][Full Text] [Related]
10. Systematic review: Clostridium difficile and inflammatory bowel disease.
Goodhand JR; Alazawi W; Rampton DS
Aliment Pharmacol Ther; 2011 Feb; 33(4):428-41. PubMed ID: 21198703
[TBL] [Abstract][Full Text] [Related]
11. Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease.
Hanada Y; Khanna S; Loftus EV; Raffals LE; Pardi DS
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):528-533. PubMed ID: 29037938
[TBL] [Abstract][Full Text] [Related]
12. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
[TBL] [Abstract][Full Text] [Related]
13. The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease.
Saffouri G; Gupta A; Loftus EV; Baddour LM; Pardi DS; Khanna S
Scand J Gastroenterol; 2017 Nov; 52(11):1240-1247. PubMed ID: 28782372
[TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Fischer M; Kao D; Kelly C; Kuchipudi A; Jafri SM; Blumenkehl M; Rex D; Mellow M; Kaur N; Sokol H; Cook G; Hamilton MJ; Phelps E; Sipe B; Xu H; Allegretti JR
Inflamm Bowel Dis; 2016 Oct; 22(10):2402-9. PubMed ID: 27580384
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: the impact of Clostridium difficile infection on the short- and long-term risks of colectomy in inflammatory bowel disease.
Law CC; Tariq R; Khanna S; Murthy S; McCurdy JD
Aliment Pharmacol Ther; 2017 Apr; 45(8):1011-1020. PubMed ID: 28206678
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis.
Navaneethan U; Mukewar S; Venkatesh PG; Lopez R; Shen B
J Crohns Colitis; 2012 Apr; 6(3):330-6. PubMed ID: 22405170
[TBL] [Abstract][Full Text] [Related]
17. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
[TBL] [Abstract][Full Text] [Related]
18. Impact of Clostridium difficile on inflammatory bowel disease.
Ananthakrishnan AN; Binion DG
Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):589-600. PubMed ID: 20932144
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors.
Banaszkiewicz A; Kowalska-Duplaga K; Pytrus T; Pituch H; Radzikowski A
Inflamm Bowel Dis; 2012 May; 18(5):844-8. PubMed ID: 21936029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
